Terapia conservativa della neoplasia renale parenchimale.

A. Cozzoli; D. Belussi; G. Pezzotti; D. Zani; L. Tralce; G. Cancarini; A. Ranieri; R. Hurle; S. Cosciani Cunico; A. Lembo

Terapia conservativa della neoplasia renale parenchimale.

Translated title of the contribution: Conservative therapy of renal parenchymal neoplasia

A. Cozzoli, D. Belussi, G. Pezzotti, D. Zani, L. Tralce, G. Cancarini, A. Ranieri, R. Hurle, S. Cosciani Cunico, A. Lembo

Istituto Clinico Humanitas

Research output: Contribution to journal › Article › peer-review

Abstract

We review our overall experience in 1375 patients, who underwent surgery for renal cell carcinoma in the Departments of Urology of Brescia and Bergamo from 1983 to 1996. 185 (13.4%) patients had nephron-sparing surgery: imperative procedure was performed in 74 cases, while an elective surgery was done in 111 patients. Three years minimal follow up was considered in order to evaluate the outcome of surgical treatment in 48 patients who underwent imperative nephron-sparing surgery and in 73 with an elective procedure. Disease specific survival was 80.8% in the first group and it was 97% in the latter.

Translated title of the contribution	Conservative therapy of renal parenchymal neoplasia
Original language	Italian
Pages (from-to)	109-115
Number of pages	7
Journal	Archivio Italiano di Urologia e Andrologia
Volume	69
Issue number	2
Publication status	Published - Apr 1997

ASJC Scopus subject areas

Nephrology
Urology

Cite this

@article{da856617c5dc4e4ebd99e6f95e13b905,

title = "Terapia conservativa della neoplasia renale parenchimale.",

abstract = "We review our overall experience in 1375 patients, who underwent surgery for renal cell carcinoma in the Departments of Urology of Brescia and Bergamo from 1983 to 1996. 185 (13.4%) patients had nephron-sparing surgery: imperative procedure was performed in 74 cases, while an elective surgery was done in 111 patients. Three years minimal follow up was considered in order to evaluate the outcome of surgical treatment in 48 patients who underwent imperative nephron-sparing surgery and in 73 with an elective procedure. Disease specific survival was 80.8% in the first group and it was 97% in the latter.",

author = "A. Cozzoli and D. Belussi and G. Pezzotti and D. Zani and L. Tralce and G. Cancarini and A. Ranieri and R. Hurle and {Cosciani Cunico}, S. and A. Lembo",

year = "1997",

month = apr,

language = "Italian",

volume = "69",

pages = "109--115",

journal = "Archivio Italiano di Urologia Nefrologia Andrologia",

issn = "1120-8538",

publisher = "Edizioni Scripta Manent s.n.c.",

number = "2",

}

TY - JOUR

T1 - Terapia conservativa della neoplasia renale parenchimale.

AU - Cozzoli, A.

AU - Belussi, D.

AU - Pezzotti, G.

AU - Zani, D.

AU - Tralce, L.

AU - Cancarini, G.

AU - Ranieri, A.

AU - Hurle, R.

AU - Cosciani Cunico, S.

AU - Lembo, A.

PY - 1997/4

Y1 - 1997/4

N2 - We review our overall experience in 1375 patients, who underwent surgery for renal cell carcinoma in the Departments of Urology of Brescia and Bergamo from 1983 to 1996. 185 (13.4%) patients had nephron-sparing surgery: imperative procedure was performed in 74 cases, while an elective surgery was done in 111 patients. Three years minimal follow up was considered in order to evaluate the outcome of surgical treatment in 48 patients who underwent imperative nephron-sparing surgery and in 73 with an elective procedure. Disease specific survival was 80.8% in the first group and it was 97% in the latter.

AB - We review our overall experience in 1375 patients, who underwent surgery for renal cell carcinoma in the Departments of Urology of Brescia and Bergamo from 1983 to 1996. 185 (13.4%) patients had nephron-sparing surgery: imperative procedure was performed in 74 cases, while an elective surgery was done in 111 patients. Three years minimal follow up was considered in order to evaluate the outcome of surgical treatment in 48 patients who underwent imperative nephron-sparing surgery and in 73 with an elective procedure. Disease specific survival was 80.8% in the first group and it was 97% in the latter.

UR - http://www.scopus.com/inward/record.url?scp=0031114513&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031114513&partnerID=8YFLogxK

M3 - Articolo

C2 - 9213495

AN - SCOPUS:0031114513

VL - 69

SP - 109

EP - 115

JO - Archivio Italiano di Urologia Nefrologia Andrologia

JF - Archivio Italiano di Urologia Nefrologia Andrologia

SN - 1120-8538

IS - 2

ER -

Terapia conservativa della neoplasia renale parenchimale.

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this